Skip to main content
Timothy Burns, MD, Oncology, Columbus, OH

TimothyFBurnsMDPhD

Oncology Columbus, OH

Thoracic Cancer

Professor of Medicine, Division of Medical Oncology

Dr. Burns is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Burns' full profile

Already have an account?

  • Office

    300 W 10th Ave
    Columbus, OH 43210
    Phone+1 614-293-5066
    Fax+1 614-293-9449

Summary

  • Dr. Burns is a Professor of Medicine, Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center. Dr. Burns completed his undergraduate work at Cornell University and earned his MD degree and PhD degree in Cell & Molecular Biology at the University of Pennsylvania. He completed his internal medicine residency and hematology-oncology fellowship at Johns Hopkins Hospital, Johns Hopkins School of Medicine. Dr. Burns joined the faculty at the University of Pittsburgh and UPMC in 2012 and recently joined the faculty at Ohio State in January of 2025. Dr. Burns continues to see lung cancer patients in the clinic however, the majority of his time is spent in the laboratory, where his focus is on characterizing key signaling pathways that are critical for the growth of non-small cell lung cancer and to develop novel targeted therapeutic approaches in EGFR mutant and MET driven mutant non-small cell lung cancer and other oncogene driven lung cancers as well as the development of targeted therapy for brain metastases. To date, Dr. Burns has published 80 cancer related publications and has received funding from the American Lung Association, the V Foundation, the LUNGevity Foundation, the Sidney Kimmel Foundation for Cancer Research, the Doris Duke Charitable Foundation, the Breath of Hope Foundation and American Cancer Society and most recently the Lung Cancer Research Foundation in addition to his R01 funding from the NCI. In the clinic, Dr. Burns has focused on developing trials to examine novel targeted therapies for oncogene driven lung cancer as well as for brain metastases.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2005

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2024 - 2026
  • PA State Medical License
    PA State Medical License 2012 - 2024
  • MD State Medical License
    MD State Medical License 2008 - 2012
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Taking on Acquired Resistance in EGFR-Mutant NSCLC
    Taking on Acquired Resistance in EGFR-Mutant NSCLCNovember 1st, 2024
  • FDA Approves Amgen Drug for Permanently Fatal Form of Lung Cancer
    FDA Approves Amgen Drug for Permanently Fatal Form of Lung CancerMay 16th, 2024
  • Lung Cancer Survival Rate in Pennsylvania Improves, Report Shows
    Lung Cancer Survival Rate in Pennsylvania Improves, Report ShowsNovember 15th, 2022
  • Join now to see all